CHP
RDHL

Cable Hill Partners’s Redhill Biopharma RDHL Stock Holding History

Cable Hill Partners’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Hold
0
– – – 937
2017
Q4 		– Sell
-1
Closed -$6.74K – 1001
2017
Q3 		$11K Buy
+1
New +$8.89K 0.01% 553

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Cable Hill Partners's RDHL Position: Q1 2018 in Review

Cable Hill Partners held its Redhill Biopharma (RDHL) position steady in Q1 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Cable Hill Partners first reported a position in RDHL in Q3 2017 and has held it in 1 quarter since. The position peaked at $11K in Q3 2017. 29 funds tracked by Wall St. Rank hold RDHL as of Q1 2018.

  • Cable Hill Partners held 0 shares of Redhill Biopharma worth $0 as of Q1 2018.
  • Cable Hill Partners left its Redhill Biopharma share count unchanged in Q1 2018.
  • Redhill Biopharma made up ﹤0.01% of Cable Hill Partners's portfolio in Q1 2018, its #937 holding.
  • Cable Hill Partners first reported a position in Redhill Biopharma in Q3 2017 and has held it in 1 quarter since.
  • Cable Hill Partners's Redhill Biopharma position peaked at $11K in Q3 2017.
  • 29 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2018.

Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.